Schizoaffective Disorder
📧 Sign up to get email alerts when something new happens for Schizoaffective Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-06-12Clinical Trial Update: Recovery Guide Intervention for Recurrent Psychiatric Hospitalization [NA]
This clinical trial evaluating a Recovery Guide Intervention for recurrent psychiatric hospitalization has completed, sponsored by Yale Univ…
-
CLINICAL_TRIALS trial_result · 2009-06-02Clinical Trial Update: Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height) [Phase 4]
This Phase 4 trial compared under-the-tongue olanzapine to swallowed olanzapine to evaluate effects on body mass index in patients with schi…
-
FDA approval · 2009-05-27FDA Approved: LOXAPINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for LOXAPINE (loxapine) from Actavis Pharma, Inc., under ANDA072205. This action represents an appro…
-
CLINICAL_TRIALS trial_result · 2009-05-19Clinical Trial Update: Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia [Phase 4]
Phase 4 trial assessing nicotine replacement therapy for smoking cessation in people with schizophrenia or schizoaffective disorder has comp…
-
CLINICAL_TRIALS trial_result · 2009-05-19Clinical Trial Update: Galantamine for Cognition in People With Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating galantamine for cognitive improvement in people with schizophrenia or schizoaffective disorder has complet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-05-15Clinical Trial Update: The Effects of Nicotine Withdrawal on Reward Responsivity in Schizophrenia [Phase 4]
A Phase 4 clinical trial examining how nicotine withdrawal affects reward responsivity in individuals with schizophrenia or schizoaffective …
-
CLINICAL_TRIALS trial_result · 2009-05-15Clinical Trial Update: Complex Problem Solving Training in Schizophrenic Patients [NA]
A Heidelberg University trial assessing complex problem solving training for patients with schizophrenia and schizoaffective disorder; the s…
-
FDA approval · 2009-04-08FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Clozapine submitted by Mylan Pharmaceuticals Inc. The action confirms regulatory clearance f…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Seroquel STACK Study in Schizophrenic or Schizoaffective Subjects [Phase 3]
The Phase 3 STACK study of quetiapine (Seroquel) for schizophrenia or schizoaffective disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-18Clinical Trial Update: Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia [NA]
A completed clinical trial update evaluating neural inhibition as a mechanism of nicotine dependence in people with schizophrenia and relate…
-
CLINICAL_TRIALS research · 2009-03-13Clinical Trial Update: An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder
This is a clinical trial update for an adherence study of antipsychotic medication in outpatients with schizophrenia or schizoaffective diso…
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: A Pharmacogenetic Investigation of Antipsychotics in Schizophrenia and Schizophrenia-Like Psychoses
A pharmacogenetic investigation of antipsychotics in schizophrenia and schizoaffective disorder has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-02-20Clinical Trial Update: Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis [Phase 2]
A Phase 2 pilot study evaluating a modified cognitive behavioral therapy approach for adolescents with early onset psychosis.
-
CLINICAL_TRIALS trial_result · 2009-02-04Clinical Trial Update: To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia [Phase 4]
This Phase 4 clinical trial compared the cost-effectiveness of olanzapine versus haloperidol for schizophrenia (including schizoaffective di…
-
CLINICAL_TRIALS trial_result · 2009-02-04Clinical Trial Update: Recovery Group Pilot [NA]
Kaiser Permanente sponsored the Recovery Group Pilot trial, which has completed. The trial targeted bipolar disorder, schizophrenia, and sch…
-
CLINICAL_TRIALS safety_alert · 2009-01-27Clinical Trial Update: Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment
A clinical trial update reports changes in heart rhythms associated with antipsychotic drug treatment, highlighting potential cardiac safety…
-
CLINICAL_TRIALS trial_result · 2009-01-27Clinical Trial Update: Donepezil Double Blind Trial for ECT Memory Disfunction [Phase 4]
Phase 4 clinical trial update on a double-blind study of donepezil for memory dysfunction after electroconvulsive therapy in schizophrenia, …
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder [NA]
This completed head-to-head clinical trial compares quetiapine with haloperidol decanoate for long-term treatment of schizophrenia and schiz…
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Generalization of Training in Schizophrenia [NA]
A completed clinical trial examining the generalization of training interventions in people with schizophrenia and schizoaffective disorder.
-
CLINICAL_TRIALS trial_result · 2009-01-07Clinical Trial Update: Cognitive - Behavioral Therapy [Phase 2]
Phase 2 trial evaluating cognitive-behavioral therapy for schizoaffective disorder and schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2008-12-11Clinical Trial Update: Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI) [Phase 4]
This clinical trial update reports the completion of a Phase 4 study evaluating injectable naltrexone for alcohol dependence in individuals …
-
CLINICAL_TRIALS research · 2008-11-11Clinical Trial Update: Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment
This clinical trial update examines plasma levels of glutamatergic amino acids and oxytocin before and after neuroleptic treatment in patien…
-
CLINICAL_TRIALS trial_result · 2008-10-24Clinical Trial Update: Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women? [Phase 2]
A Phase 2 trial of anti-estrogen therapy for bipolar affective disorder in women has completed, with related attention to mania and schizoaf…
-
CLINICAL_TRIALS trial_result · 2008-10-06Clinical Trial Update: Seroquel Long-Term NIS for Schizophrenia Patients
Completion of a long-term non-interventional study of quetiapine (Seroquel) in patients with schizophrenia and schizoaffective disorder has …
-
CLINICAL_TRIALS trial_result · 2008-08-26Clinical Trial Update: Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder [NA]
A completed clinical trial evaluating the effects of risperidone and olanzapine in patients with schizophrenia, schizoaffective disorder, ma…